| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Tejara Capital Ltd | 5.2% | $5,323,528 | 5,130,122 | Tejara Capital Ltd | 17 Oct 2025 |
As of 30 Sep 2025, 47 institutional investors reported holding 7,282,619 shares of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL). This represents 7.4% of the company’s total 98,656,192 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 16,552 | $16,552 | -$218 | $1.00 | 1 |
| 2025 Q3 | 7,282,619 | $7,797,682 | +$687,878 | $1.07 | 47 |
| 2025 Q2 | 6,465,422 | $8,796,830 | -$1,669,185 | $1.36 | 38 |
| 2025 Q1 | 7,709,601 | $7,425,491 | +$182,306 | $0.97 | 37 |
| 2024 Q4 | 7,481,601 | $9,584,771 | +$3,010,014 | $1.28 | 41 |
| 2024 Q3 | 4,972,209 | $9,851,950 | -$780,397 | $1.98 | 40 |
| 2024 Q2 | 5,390,695 | $10,831,844 | -$2,328,728 | $2.02 | 40 |
| 2024 Q1 | 6,273,385 | $11,371,497 | +$17,317 | $1.81 | 30 |
| 2023 Q4 | 6,826,516 | $5,919,645 | +$428,284 | $0.84 | 30 |
| 2023 Q3 | 6,312,413 | $5,702,507 | -$336,334 | $0.90 | 29 |
| 2023 Q2 | 6,677,805 | $5,954,756 | -$452,379 | $0.89 | 28 |
| 2023 Q1 | 7,236,637 | $3,532,883 | +$204,759 | $0.49 | 29 |
| 2022 Q4 | 5,480,509 | $2,792,996 | +$220,955 | $0.51 | 25 |
| 2022 Q3 | 6,399 | $4,000 | -$58,661 | $0.71 | 3 |
| 2022 Q2 | 5,192,142 | $6,837,000 | -$80,069 | $1.32 | 22 |
| 2022 Q1 | 5,264,558 | $8,084,489 | -$1,067,974 | $1.54 | 22 |
| 2021 Q4 | 5,790,080 | $10,700,000 | +$7,691,063 | $1.85 | 26 |
| 2021 Q3 | 1,599,991 | $6,600,000 | +$6,600,002 | $4.14 | 18 |
| 2021 Q1 | 0 | $0 | -$969,996 | $1.00 | 0 |
| 2020 Q4 | 348,769 | $970,000 | +$171,497 | $2.78 | 1 |
| 2020 Q3 | 287,106 | $876,000 | +$133,034 | $3.05 | 1 |
| 2020 Q2 | 243,504 | $577,000 | +$78,277 | $2.37 | 1 |
| 2020 Q1 | 210,470 | $600,000 | +$50,716 | $2.85 | 1 |
| 2019 Q4 | 192,680 | $681,000 | $0 | $3.53 | 1 |